Service and Experience

Cognate has experience in designing, building, implementing, and operating cGMP manufacturing infrastructure for autologous and allogeneic cell and cell-mediated therapy products in the US and abroad. When our current capacity does not meet the needs of your product or market, or you want to plan for a 2, 5, 10-or-more year commercial runway, we can work with you on a custom configuration in our available US expansion space, in an adjacent stand-alone facility, or in other geographies globally.

We can automate parts of your process including working with a 3rd party provider to create a modular fully-closed process that scales.

We offer a wide variety of services to ensure your clinical and/or commercial products are ready to meet patient demand.